ALHA
Candidate Overview
Ag85A-LpqH (AL) is a recombinant subunit vaccine that combines the T cell-stimulating antigen Ag85A with the humoral immunity-targeting antigen LpqH. It is constructed using the pET-21a(+) vector, expressed in E. coli BL21(DE3), and formulated with aluminum for subcutaneous administration.
Sponsor / Lead Developer: China Agricultural University
Primary Indication: Prevention of Mtb infection or sustained infection
Other Indication(s): Immunotherapy/Improving TB Cure Rates, Immunotherapy/Shortening TB treatment, Prevention of TB disease, and Prevention of TB recurrence
Target Population(s): Adolescents, Adults, Children, Elderly, Infants, People cured of active TB, People living with HIV, People with active TB, People with MDR-TB, People with Mtb infection, and People without Mtb infection
Target Route of Administration: Intramuscular
Immune tissue localization: Lung and Lymph node
Immunological responses: B-cell/Antibody and T-cell
Preclinical Animal Models: Mouse
Intended to elicit trained immunity: No
Additional Immunologic Response Information
HYPOTHESIZED | DEMONSTRATED |
|
| Immune Response | T-cell B-cell/Antibody |
|
| T-cell phenotype | CD4 CD8 Th1 |
|
| T-cell functional profile | IFN-γ TNF-α IL-17 Cytolytic capacity Mycobacterial growth inhibition |
|
| Characteristics of B-cell response | 1.Strong antibody response: High titers of IgG (including IgG1, IgG2c, IgG3), IgM, and IgA, especially in the ALA group. 2.Long lasting immunity: Antibody levels remain high up to 4 weeks post infection. 3.Protective function: Serum enhances macrophage phagocytosis and reduces bacterial load and lung damage. 4.Increased BCR diversity: Notable rise in BCR diversity (IGL/IGK), with distinct V J gene usage. 5.IgG1 dominance: BCR repertoire shows higher IgG, particularly IgG1. | |
| Preferential immune tissue localization | Lung | Lymph node |
| Trained immunity | Yes | |
Related Publications
Additional Information
Additional target population: Highly exposed populations such as healthcare workers and community workers who have contact with TB patients.